Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
Stage/Subtype:  Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
Trial Type:  Treatment
Results 1-4 of 4 for your search:
Start Over
Panobinostat, Bortezomib, and Vincristine Sulfate Liposome with Re-induction Therapy in Treating Younger Patients with Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or Lymphoma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and under
Trial IDs: TSALV, NCI-2015-00935, NCT02518750
Genetically Modified T Cells in Treating Younger Patients with Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: Under 26
Trial IDs: 13-052, NCI-2013-01076, NCT01860937
Nivolumab and Dasatinib in Treating Patients with Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Not yet active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: NU 15H13, NCI-2016-00711, STU00202846, NCT02819804
Fludarabine Phosphate, Busulfan, Anti-thymocyte Globulin, and Total-Body Irradiation before Donor Stem Cell Transplant in Treating Younger Patients with Leukemia
Status: Active
Phase: No phase specified
Type: Treatment
Age: 21 and under
Trial IDs: SCT 0208, NCI-2015-00140, CMH SCT 0208, NCT00679536
Start Over